EMA Authorised: Byfavo (remimazolam besilate) — Paion Pharma GmbH

View source ↗

Summary

Authorised status for Byfavo (remimazolam besilate) by Paion Pharma GmbH for conscious sedation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conscious Sedation-related Indications

Drugs mentioned

• Byfavo (remimazolam)

Snippet

Status: Authorised. Therapeutic area: Conscious Sedation. MAH: Paion Pharma GmbH. Decision date: 19/08/2026